{
  "retracted": false,
  "timestamp": 1393891200000,
  "updates": [
    {
      "timestamp": 1574695395257,
      "identifier": {
        "doi": "10.1007/s00415-014-7280-4"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s00415-013-7115-8"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study"
}
